143 related articles for article (PubMed ID: 4195146)
1. L.A.T.S. and Graves' disease.
Hedley AJ; Ross IP; Crooks J
Lancet; 1970 Aug; 2(7670):468-9. PubMed ID: 4195146
[No Abstract] [Full Text] [Related]
2. Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.
McKenzie JM; McCullagh EP
J Clin Endocrinol Metab; 1968 Aug; 28(8):1177-82. PubMed ID: 4175472
[No Abstract] [Full Text] [Related]
3. The long-acting thyroid stimulator and the result of I 131 treatment for thyrotoxicosis.
Martin FI; Larkins RG; Alford FP; Andrews JT; Greenberg PB; Melick RA; Penington JS
Aust N Z J Med; 1972 May; 2(2):168-72. PubMed ID: 4116447
[No Abstract] [Full Text] [Related]
4. Does LATS cause hyperthyroidism in Graves' disease? (A review biased toward the affirmative).
McKenzie JM
Metabolism; 1972 Sep; 21(9):883-94. PubMed ID: 4115791
[No Abstract] [Full Text] [Related]
5. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
[No Abstract] [Full Text] [Related]
6. [Clinical studies of long-acting thyroid stimulator].
Eguchi Y
Nihon Naibunpi Gakkai Zasshi; 1970 Nov; 46(8):939-52. PubMed ID: 4099204
[No Abstract] [Full Text] [Related]
7. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases].
Depisch D; Höfer R; Schatz H
Wien Z Inn Med; 1968; 49(4):121-30. PubMed ID: 5757238
[No Abstract] [Full Text] [Related]
8. [Incidence of L.A.T.S. demonstration in untreated recent hyperthyroidism. Comparison of 2 continuous series].
Mornex R; Massin JP; Orgiazzi J; Savoie JC
Ann Endocrinol (Paris); 1972; 33(2):177-84. PubMed ID: 4678455
[No Abstract] [Full Text] [Related]
9. Positive correlation of the long-acting thyroid stimulator (LATS) with the percentage of endogenously labelled 131 I triiodothyronine in the plasma of hyperthyroid patients.
Emrich D; Albani M; zur Mühlen A von
Acta Endocrinol (Copenh); 1971 Nov; 68(3):445-50. PubMed ID: 4107957
[No Abstract] [Full Text] [Related]
10. [The long acting thyroid stimulator (LATS) in some thyroid diseases. Preliminary results].
Busnardo B; Accordi F; Debiasi S
Acta Isot (Padova); 1968 Oct; 8(2):165-79. PubMed ID: 5761578
[No Abstract] [Full Text] [Related]
11. [Characterization of the long-acting thyroid stimulator. Considerations on preliminary results].
Tourneur R; Letonturier P; Sénécal P
MMW Munch Med Wochenschr; 1974 Mar; 116(13):677-9. PubMed ID: 4212576
[No Abstract] [Full Text] [Related]
12. Large doses of radioiodide in Graves' disease: effect on ophthalmopathy and long-acting thyroid stimulator.
Pequegnat EP; Mayberry WE; McConahey WM; Wyse EP
Mayo Clin Proc; 1967 Dec; 42(12):802-11. PubMed ID: 4169552
[No Abstract] [Full Text] [Related]
13. Long-acting thyroid stimulator (LATS) in toxic nodular goitre, toxic adenoma and Graves' disease.
Lamberg BA; Gordin A; Viherkoski M; Kvist G
Acta Endocrinol (Copenh); 1969 Oct; 62(2):199-209. PubMed ID: 5394703
[No Abstract] [Full Text] [Related]
14. [Biological determination of thyrotropin and long-acting thyroid simulator].
Potin VV; Stepanov GS
Probl Endokrinol (Mosk); 1969; 15(4):64-7. PubMed ID: 5395630
[No Abstract] [Full Text] [Related]
15. Long-acting thyroid stimulator in Graves' disease.
Sellers EA; Awad AG; Schönbaum E
Lancet; 1970 Aug; 2(7668):335-8. PubMed ID: 4194442
[No Abstract] [Full Text] [Related]
16. [LATS in Graves-Basedow disease].
Nauman J; Nauman A
Pol Arch Med Wewn; 1971; 46(3):315-21. PubMed ID: 5108058
[No Abstract] [Full Text] [Related]
17. Mechanisms of Graves' disease and endocrine exophthalmos.
Anderson DR
Am J Ophthalmol; 1969 Jul; 68(1):46-57. PubMed ID: 4895778
[No Abstract] [Full Text] [Related]
18. New in vitro tests to detect the thyroid stimulator in sera from hyperthyroid patients by measuring colloid droplet formation and cyclic AMP in human thyroid slices.
Onaya T; Kotani M; Yamada T; Ochi Y
J Clin Endocrinol Metab; 1973 May; 36(5):859-66. PubMed ID: 4349046
[No Abstract] [Full Text] [Related]
19. [Significance of the "long acting thyroid stimulator"].
Tourneur R; Letonturier P; Sénécal P
Cah Med; 1974 Mar; 15(3):121-3. PubMed ID: 4479615
[No Abstract] [Full Text] [Related]
20. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
Lamberg BA; Gordin A
Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
[No Abstract] [Full Text] [Related]
[Next] [New Search]